Visitor Monitoring Drug Details: RELAFEN
 
Drugs Directory of False Positives DRUGS THAT CAUSES A FALSE POSITIVE ON A DRUG TEST
 
Browse by Letter: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Drug Details

Drug Name: RELAFEN
FDA Application No: (NDA) 019583
Active Ingredient(s): NABUMETONE
Company: SMITHKLINE BEECHAM
Original Approval or Tentative Approval Date: December 24, 1991
Chemical Type: 1 New molecular entity (NME)
Review Classification: S Standard review drug
 
There are no Therapeutic Equivalents Label Information
Approval History, Letters, Reviews and Related Documents
 
You can see the products in the same application. The table can be sorted by clicking the header columns.
 
Drug NameSort imageActive IngredientsStrengthDosage Form/RouteMarketing StatusRLDTE Code
RELAFEN NABUMETONE500MGTABLET; ORAL Discontinued No None
RELAFEN NABUMETONE750MGTABLET; ORAL Discontinued No None


Comments for RELAFEN
 
 
Name: *
 
Email: *
 
Text:
(HTML OK)
 
Enter the code from the picture: *
(click here to load another image)
 
 
  
There are no comments.
©2019 Drugs That Causes a False Positive on a Drug Test